Oral iron supplements are associated with reduced gastrointestinal tolerance and exhibit poor effectiveness in treating iron deficiency in the context of inflammation, which is related to hepcidin lowering iron absorption and preventing iron recycling, thereby limiting erythropoiesis [19]. This evidence concerns the gene HAMP and nutritional disorder.